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PERANAN ALPHA-GIARDIN TERHADAAP UBAT DALAM GIARDIA 
INTESTINALIS 
 
 
ABSTRAK 
Giardiasis yang disebabkan oleh parasit protozoa usus, dikenali sebagai Giardia 
intestinalis, telah memberi kesan negatif kepada 280 juta penduduk dunia terutama 
kanak-kanak yang berumur lima tahun ke bawah. Pengambilan sekurang-kurangnya 
sepuluh cyst G. intestinalis boleh menyebabkan jangkitan di mana akan 
mengakibatkan komplikasi seperti dehidrasi dan kekurangan berat badan. Terdapat 
beberapa ubat yang boleh didapati untuk merawat jangkitan giardiasis namun, 
kerintangan terhadap ubat, reinfeksi dan pengulangan simptom semakin meningkat. 
Oleh itu, penghasilan ubat baharu adalah penting untuk mengawal giardiasis.  Kajian 
ini dilakukan untuk mengkaji peranan alpha-giardin disebabkan oleh ubat di dalam G. 
intestinalis. Hasil kajian menunjukkan Mebendazole (MBZ) lebih berkesan terhadap 
G. intestinalis dengan nilai IC50 sebanyak 0.06 jika dibandingkan dengan 
Metronidazole (MTZ) iaitu sebanyak 9.177. Trofozoit pada nilai kepekatan ubat 
yang tinggi menunjukkan pengurangan pertumbuhan secara signifikan. Radikal 
bebas tidak dapat dikesan apabila menggunakan MBZ dan MTZ. Selain itu, G. 
intestinalis yang dirawat menggunakan 100 µM MBZ dan MTZ menunjukkan 
ekspresi alpha-2 giardin yang signifikan (p ≤ 0.05). Kesimpulannya, alpha-2 giardin 
berpotensi untuk dijadikan penanda dalam penghasilan ubat atau vaksin baru bagi 
mengawal jangkitan giardiasis.  
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THE ROLE OF ALPHA-GIARDIN IN RESPONSE TO DRUG TREATMENT 
IN GIARDIA INTESTINALIS 
 
ABSTRACT 
Giardiasis, which is caused by the intestinal protozoan parasite Giardia intestinalis, 
affects approximately 280 million people around the world, particularly in children 
below five years of age. Oral ingestion of as few as ten cysts of G. intestinalis can 
cause infection in human which lead to complications such as severe dehydration and 
weight loss. There are several antigiardial drugs available for giardiasis treatment; 
however, issues such as drug resistance, reinfection and recurrence of symptoms 
have been highly reported. Thus, the finding for a novel potential drug targets is 
important to control giardiasis. In this study, we sought to examine the role of alpha-
giardins in response to drug treatment in G. intestinalis. Our results showed that G. 
intestinalis were more susceptible to the action of Mebendazole (MBZ) as the IC50 
value for MBZ was 0.06 µM when compared with Metronidazole (MTZ) of 9.177 
µM. Trophozoites treated with high concentration of MBZ or MTZ showed 
significant reduction in viability. The release of reactive oxygen species were not 
detected in either MBZ or MTZ-treated G. intestinalis. We also found that G. 
intestinalis treated with 100 µM MBZ or MTZ showed significant upregulated 
expression of alpha-2 giardin (p ≤ 0.05). In conclusion, alpha-2 giardin could serve 
as a novel potential target for future drug design and vaccine development. 
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SECTION 1 
CHAPTER ONE 
GENERAL INTRODUCTION. 
1.1 Overview 
Giardiasis is a worldwide health problem that requires public attention. The causative 
agent for human giardiasis, Giardia intestinalis, is an anaerobic flagellated protozoan 
that affected over 200 million people with 500,000 new cases being reported 
annually (Painter et al., 2015, Ankarklev et al., 2010). It is accounted as one of the 
most common diarrheal diseases among children aged less than five years old (Ehsan 
et al., 2017). Giardiasis occurrence is on a decreasing trend due to the effectiveness 
of current treatment. However, side effects and drug resistance as well as re-
occurrence are still a problem. Thus, the search for new drug or drug targets is 
important to prevent the disease. 
 Although giardiasis infections are mostly asymptomatic, chronic and 
persistent diarrhea could be seen in symptomatic patients (Minetti et al., 2016). This 
can cause life threatening situation especially among younger children living in third 
world country where access to medicine are limited. Besides, the affected children 
showed growth disorders although the giardiasis infections are cleared. Most children 
with Giardia infection, show growth retardation and reduced weight when compared 
to those uninfected children (Fraser et al., 2000). 
 The current standard antigiardial drug is 5-nitro derivatives of imidazole 
groups (metronidazole, tinidazole), furan (furazolidone) and thiazole (nitazoxanide).  
Alternative drugs are acridines (quinacrine, chloroquine), aminoglycosides 
(paromomycin) and benzimidazoles (albendazole, mebendazole) (Cañete, 2016). 
12 
 
Even though these drugs are effective for the control of giardiasis, issues related to 
side effects, recurrence and resistance still exist. For example, furazolidone may 
cause complications in patient of a certain genotype (G6PDH-deficient patient) and 
quinacrine can lead to yellow discoloration of skin, long term use of albendazole has 
caused reversible neutropenia (Gardner and Hill, 2001). Recurrences after drug 
treatment have also become big issue. According to Hanevik and colleagues, the 
persistence of chronic giardiasis is as high as 32% 7 months after infection. In 
another study, chronic symptoms such as irritable bowel syndrome and chronic 
fatigue still persist in infected patients 6 years after Giardia infection (Hanevik et al., 
2014). The development of resistance towards most antigiardial drugs has also 
become one of the arising issues. The resistance to metronidazole occurs in 20% of 
cases (Jarrad et al., 2016). Therefore, the identification of new drug targets is vital to 
solve this problem. 
 Cytoskeleton of the Giardia is important in pathogenicity as well as in 
supporting its motility, ability to attach to the mucosa and resistance against 
degradation by bile salts for Giardia survival in host’s body (Elmendorf et al., 2003). 
Cytoskeleton of the Giardia consists of tubulin as well as four different giardin 
families which are the alpha-giardins, beta-giardins, gamma-giardins and delta-
giardins. In Giardia, 21 alpha-giardins have been identified and they are assigned to 
the family E annexins (Morrison et al., 2007). According to Weiland and colleagues 
(Weiland et al., 2005), most alpha-giardins are localized to the plasma membrane and 
flagella, while only a few are attached to the adhesive disc of the trophozoites. 
Recent finding by Paz Maldonado and colleagues (Paz-Maldonado et al., 2013), 
showed that alpha-2-giardin was upregulated in G.intestinalis when exposed to 
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albendazole. However, another contrary report showed that alpha-giardins were 
down-regulated under metronidazole-induced stress (Ansell et al., 2016). 
 The plant annexin, Arabidopsis thaliana, AnnAt1 (annexin 1), has been 
identified to play an important role in protecting cells from oxidative stress 
(Konopka-Postupolska et al., 2009). Since annexins of Taenia and Schistosoma spp 
have been shown to protect cells from oxidative stress (Hofmann et al., 2010), it is 
postulated that alpha-giardins may also protect Giardia from drug-induced oxidative 
stress. Hence, the understanding of whether alpha-giardins help Giardia to survive 
under drug-induced oxidative stress in the host is important in order to identify new 
drug targets to combat giardiasis. 
 
1.2 Introduction to Giardia intestinalis 
Giardia intestinalis, also known as Giardia lamblia or Giardia duodenalis, is the 
protozoan parasite causes chronic diarrheal diseases worldwide. Infection is acquired 
through ingestion of cysts from contaminated water or food, or through fecal-oral 
route (Einarsson et al., 2016). G. intestinalis exists in two distinct forms in the 
environment, the trophozoites (vegetative form) and the cyst (infective form). During 
trophozoite stage, these parasites will multiply and reproduce asexually in the host’s 
small intestine, while cysts will be shed to the environment through the host’s feces 
and transmit the disease (Weiland et al., 2005).  
G. intestinalis is a member of the family Hexamitidae, order Diplomonadida, 
class Zoomastigophora and of phylum Sarcomastigophora. Currently, there are 40 
Giardia species that have been identified, and only six have been morphologically 
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recognized (Feng and Xiao, 2011). G. intestinalis is the only species that causes 
infection in humans and a variety of animals. G. muris infects rodents whereas G. 
aredeae and G. psittaci infect birds. G. agilis is found to infect amphibians (Lopez‐
Romero et al., 2015). 
There are eight assemblages (genotypes) exist that infect a wide range of 
mammals and humans. These assemblages are named as assemblage A-H (Heyworth, 
2016). The assemblages A and B have been found to cause infection in humans and 
other mammals. However, other assemblages including C, D, E, F, G and H do not 
cause infection in human. Assemblage C and D infect domestic animals such as dogs 
while assemblage E infect hoofed animals, domestic ruminants and pigs. Assemblage 
F infects cats, assemblage G infects rodents such as mice, and assemblage H infects 
seals (Feng and Xiao, 2011, Lopez‐Romero et al., 2015). Figure 1.1 shows the 
established Giardia species and G. intestinalis assemblages. 
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Figure 1.1 Giardia species and G. intestinalis assemblages 
Source: Feng & Xiao (2011) 
 
Giardia trophozoite was first discovered by Antony van Leeuwenhoek, a 
Dutch microscopist in 1681 after he observed his own diarrheal feces and named this 
protozoan as G. intestinalis (Adam, 2001). However, he did not make further 
observation on the pathology of this parasite. G. intestinalis was then further studied 
and described by Vilem Lambl in 1859. He observed the presence of this parasite in 
the stools of children with diarrhea. However, he believed that this parasite was a 
commensal and not responsible to cause infection. The controversy about the number 
of Giardia species continued for many years and more than 40 names have been 
proposed by few investigators during the first half of the 20
th
 century. The species 
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was later widely known as G. lamblia and G. intestinalis in the medical field. This 
parasite has been recognized as pathogenic in the late 1970s (Ford, 2005). However, 
these parasites are non-invasive as it remains confined to the lumen of small intestine 
and do not spread via bloodstream or gastrointestinal tract. 
 
1.2.1 Epidemiology of Giardiasis 
The epidemiologic distribution of Giardia in human population is due to the 
exposure and ingestion of infectious cysts through contaminated water and food, or 
through fecal oral infection. The estimated prevalence of Giardia infections range 
between 2% and 5% in developed countries, and 20% to 30% in developing 
countries (Roxström-Lindquist et al., 2006). Giardia infection showed high 
prevalence rate in children less than ten years old (Painter et al., 2015). The highest 
prevalence of giardiasis occurrence has been reported in western Nepal with 73.4%, 
and this is mostly due to poor sanitation. In the United States, giardiasis has been 
notified since 2002 with about 2.5 million cases reported annually. The insufficient 
of clean water supplies appear as the cause of diarrhea among travellers to the 
regions of Africa, Asia and Latin America (Abbas et al., 2011).  
According to a surveillance survey of giardiasis during 2011 and 2012, there 
are 16, 868 cases in 2011, and 15, 223 cases in 2012 per 100 000 population in 2011 
and 5.8 in 2012. Giardiasis has been identified as the main cause of diarrhea among 
young children aged 1-9 years old. The occurrence in children may be related to the 
increased recreational water exposure, poor hygiene practices and close contact with 
infected children in child care center. The occurrence of giardiasis also has been 
reported to be higher among males especially in adults, which might be due to their 
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higher exposure to outdoor activities, occupation status and homosexual practices 
(Painter et al., 2015).  
  In Malaysia, the prevalence of giardiasis could be underreported. The 
prevalence of giardiasis was the highest among aboriginal communities (29.2%), 
with higher cases diagnosed in West Malaysia as compared to East Malaysia (Choy 
et al., 2014). Giardiasis has been found to be the highest among aboriginal 
communities in Pahang (15.9%), followed by Negeri Sembilan (14.9%) and Kedah 
(13.4%). However, the cases were found to be low among communities from 
Malacca (4.6%). The occurrence of Giardia infection was high among aboriginal 
communities in West Malaysia especially in children aged less than 12 years old. 
This is caused by the factors such as inadequate sanitary and healthcare facilities, no 
clean water supply, poor hygiene practices, lack of health education and poor 
housing conditions (Mohamed et al., 2008). Figure 1.2 shows the distribution of 
giardiasis in Malaysia. 
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Figure 1.2 Occurence of Giardiasis in Malaysia.  
A geographic map showing the location of district (stars) and states 
(coloured) involved. 
Source : Choy et al., (2014) 
 
1.2.2 Morphology and life cycle  
G. intestinalis is an unique organism as it possesses two equal sized nuclei that are 
similar in appearance, DNA content, transcription and time of replication (Morrison 
et al., 2007). It has two different stages of development, the trophozoites and the cyst. 
The trophozoites have a pear shaped body with convex dorsal side and an enlarged 
anterior and narrower posterior. The size ranges from 8 to 20 µm long and 5 to 16 
µm wide with an average length range from 10 to 15 µm. Giardia trophozoites 
contain two nuclei and median bodies with four pairs of flagella which are anterior, 
posterior, ventral and caudal flagella that help in locomotion and attachment to the 
host’s intestines (Adam, 2001). Giardia trophozoite is lack of mitochondria, 
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peroxisome, rough endoplasmic reticulum and Golgi apparatus. However, it has a 
unique and complex cytoskeleton structure, consists of microtubules and 
microfilaments which aids in cell motility (Elmendorf et al., 2003). 
The cysts which are responsible to cause disease are oval and elliptically 
shaped. The size ranges from 8 to 19 µm long and 7 to 10 µm wide. Each cyst 
contains four nuclei, four median bodies and is covered by 0.3 to 0.5 µm thick cyst 
wall. The cyst wall is composed of β-1, 3-N-acetyl-D-Galactoseamine polymers and 
cysteine that surrounds the outer filamentous layer and inner membrane layer 
(Ringqvist, 2009). Giardia cysts are very resistant to the environmental stress 
including chlorination, UV exposure and freezing. Hence, they can survive for 
several months in cold water and are responsible for the disease transmission (Painter 
et al., 2015).  
 
Figure 1.3 Morphological characteristics of the trophozoite (a) and cyst (b) of 
Giardia 
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The life cycle of G. intestinalis is very direct and simple, in which it only 
involves two stages, the excystation and encystation stages. Giardia infection in the 
host begins through ingestion of cyst through contaminated drinking water or food, 
or via fecal-oral route (Weiland et al., 2005). The infectious doses are about 25 to 
100 cysts; however ten cysts are sufficient enough to cause infection in human as it 
can reproduce in the small intestine. The excystation stage takes place when the 
ingested cysts traveled through the host’s digestive system and excyst to become 
trophozoites in the duodenum. The excystation process was stimulated by the acidic 
environment in the stomach of the host. The low pH of the stomach acid and the 
influx of bile from the gall bladder lead to the loss of cyst wall’s rigidity. Releasing 
excyzoite then will divide and produce trophozoites in the duodenum and jejunum of 
the host (Bernander et al., 2001, Adam, 2001, Ringqvist, 2009). Each cyst will divide 
twice and produce four trophozoites during the excystation stage.  
The trophozoites will then attach to the intestinal epithelial cell by using 
adhesive disk that are resistant to be removed via bulk flow in the intestinal lumen 
(Einarsson et al., 2016, Lopez‐Romero et al., 2015). During attachment in the small 
intestine, the trophozoites reproduce asexually by longitudinal binary fission and 
either remains in the lumen of the proximal small bowel as free organism or being 
attached to the mucous lumen by a ventral sucking disk. As the trophozoites 
transported down to the colon, the encystation stage will take place due to exposure 
to the bile salts and fatty acids. Alkaline pH, the presence of high level of bile and 
low level of cholesterol will trigger the encystation process of Giardia trophozoite 
(Lauwaet et al., 2007). During the process, the trophozoites disc will disassemble and 
compartmentalize structural organelles and reform to the shape of the cyst. The 
encystation stage is complex and involves downregulation of trophozoite-specific 
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genes and induction of encystation-specific gene (Hill and Nash, 1995). In the early 
phase, the encystation-specific vesicles will develop and mature as well as other 
proteins and protease. The late phase of encystation involves changes of the gene 
expression, transportation of the cyst wall protein to the cell surface, the assembly of 
trophozoites with N-acetylgalactosamine (GalNAc) into the cyst wall and DNA 
replication (Einarsson et al., 2016, Hill and Nash, 1995). The cysts will then are 
passed to the environment and are able to survive for months outside the host. About 
300 million of cysts can be shed through the feces of infected individuals (Ford, 
2005). As the cysts can survive for a long period of time especially in the damp and 
cool environment, the life cycle will be repeated again. Figure 1.4 shows the 
summary of G. intestinalis life cycle. 
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Figure 1.4 Life cycle of G. intestinalis 
Source : www.cdc.gov 
 
1.2.3 Transmission routes of Giardiasis 
Giardia infection can be found worldwide especially in the areas with poor sanitation 
and contaminated water supply (Einarsson et al., 2016). In humans, giardiasis can be 
acquired through the consumption of untreated or improperly treated contaminated 
water, ingestion of contaminated uncooked foods especially vegetables or fruits, or 
by intimate contact with infected individuals through fecal-oral route (Painter et al., 
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2015). Giardia infection can also occur through direct zoonotic transmissions from 
pets (cats and dogs) to human. Although giardiasis most commonly affects travellers 
and those camps in the wilderness, anyone is at risk of being infected. The high risk 
groups of exposure to Giardia infection includes children in childcare settings, those 
having close contacts with infected people, those consume contaminated water and 
foods, those involved with water activity such as swimming and playing in 
recreational water especially in lakes, ponds, rivers and streams, those who have 
contacted with infected animals, and individuals exposed to human feces through 
sexual contact (Roxström-Lindquist et al., 2006).   
 According to Yoder and colleagues (Yoder et al., 2012), the occurrence of 
giardiasis commonly shows seasonal variability in which the number of cases are 
higher during summer and early autumn in temperate countries. It is probably due to 
the increased of outdoor activities during warm season which leads to the exposure 
of contaminated waters. In the United States, the reported cases of giardiasis are 
higher in northern states as compared to the south of the city. This is most likely due 
to the increase of cyst viability in colder climates (Yoder et al., 2010).  
 Giardiasis also shows a bimodal age-related distribution in which most of the 
cases occurred among children under ten and adults aged between 25 and 44 years of 
age (Yoder et al., 2012). This is probably caused by the differences in the immune 
status or the frequency of exposure among different age groups. The higher cases of 
Giardia infection among children under ten are probably caused by the poor sanitary 
practices in day care centers (Mohamed et al., 2008). Giardiasis is higher in males as 
compared to females. This is probably due to the sexual transmission among 
homosexual men practicing anal-oral sexual (Yoder et al., 2012).  
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1.3 Host-parasite interaction 
Giardiasis is one of the major gastrointestinal diseases throughout the world which is 
caused by the protozoan parasite Giardia intestinalis. It is the most common 
protozoan infection that causes 280 million cases annually. This disease affects 
human especially children, and seen mostly in developing and industrialized 
countries (Yoder et al., 2012).  
The interaction between Giardia trophozoites and the intestinal epithelial 
cells (IECs) of the host have been characterized in vitro cell culture systems and in 
vivo (rodent) models (Dreesen et al., 2014). The mechanism of the disease is still 
poorly understood, however it is thought to be multifactorial due to the parasite 
genetic makeup, the host age, gender, nutritional and immune status as well as the 
presence of other diseases or infections (Cotton et al., 2011). According to Ankarklev 
and colleagues (Ankarklev et al., 2010), Giardia is not invasive compared to other 
intestinal parasites and it does not secrete any known toxins.  
Cysts are one of the virulence factors for Giardia infection. Cysts can survive 
for several weeks in the environment especially in fresh waters, untreated 
wastewaters and agricultural run-off from manure-fertilized fields (Plutzer et al., 
2010). Other virulence factors are the trophozoite adhesive disk, flagella and the 
variant surface proteins (VSPs). These trophozoites structures are important for their 
attachment to the host cell, and to keep them from being excreted by the complete 
clearance of human immune system (Ringqvist, 2009). 
Giardia infection was acquired through the ingestion of cysts. The emerging 
trophozoites of Giardia will inhabit and attach to the mucosal surface of host’s small 
intestine and replicate by binary fission. The shortening of microvilli and inhibition 
